Skip to content

Step Into Support for Endurance and Strength (SISTERS)

Step Into Support for Endurance and Strength (SISTERS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04354454
Acronym
SISTERS
Enrollment
21
Registered
2020-04-21
Start date
2021-01-29
Completion date
2023-03-17
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer

Keywords

Gynecologic Cancer, Mobile Health, Fitness Tracker, Survivorship, Quality of Life, Physical Activity, Feasibility Study, Pilot

Brief summary

The Step into Support for Endurance and Strength (SISTERS) research study is evaluating whether a mobile health game designed to increase physical activity is feasible and acceptable in patients with gynecologic cancers. -SISTERS is testing a mobile health intervention can help increase physical activity. Participants will be randomized to receive either 1) a Fitbit or 2) a Fitbit + a game + help from a friend or family member whom you chose will help the participant reach their goals. (i.e. a Teammate).

Detailed description

This study is a two-arm randomized controlled pilot study designed to test the feasibility and acceptability of using a wearable accelerometer (Fitbit) vs. a wearable accelerometer (FItbit) + a game designed to help participants increase physical activity + social support improves participants' average daily step counts. Eligible Participants will be randomly assigned into 1 of 2 groups 1. Fitbit (wearable accelerometer) or 2. Fitbit (wearable accelerometer) + game + help from a self-selected teammate The study interventions involved in this research are: * Surveys/Interviews * Fitbits (also known as a wearable accelerometers or fitness trackers) * Way to Health Platform * Help from a Teammate (i.e. a friend or family member that participants choose to help them reach their goals) It is expected that about 50 people will take part in this research study.

Interventions

OTHERFitbit

Participants will select a daily step goal and track their steps every day for 4.5 months.

OTHERFitbit + Game + Support from a Teammate

Daily Fitbit tracking for 4.5 months, divided into 2 parts. * 3 months on active intervention with Fitbit, a Game, and Support from a self-selected Teammate and pre-designed game. * 1.5 month follow-up period with Fitbit and social support teammate only

Sponsors

Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥18 years of age with a gynecologic cancer (ovarian, fallopian tube, primary peritoneal carcinoma, uterine, or cervical) who have completed cancer treatment ≥ 6 weeks prior. * Own a smartphone (Android or iOS). * Can read and provide informed consent in English. * Do not have cognitive, visual, or orthopedic impairments that preclude participation, as evaluated by the research staff or oncology provider. * Insufficiently active, as indicated by a score of \<14 on the Leisure Score Index of Godin Leisure-Time Exercise Questionnaire (LSI). * No future chemotherapy planned (except maintenance treatments; e.g. PARP inhibitors or endocrine therapy)

Exclusion criteria

* Patients already participating in a mobile health intervention. * Patients who do not own a smartphone or computer to transmit data from the wearable tracker. * Self-reported inability to walk 2 blocks (at any pace). * Patients who are unable to identify a social support partner (i.e. family member, friend, or partner) to participate in the study (if selected for the intervention arm). * The following special populations will be excluded from this research: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Rate of Enrollment3 monthsFeasibility will be demonstrated if ≥50% eligible participants enroll
Rate of Completion3 monthsFeasibility will be demonstrated if ≥75% of eligible participants complete the post-baseline outcome assessments.
Burden Rate3 monthsAcceptability will be defined as: ≤20% of participants reporting high study burden and ≤10% study withdrawal.
Rate of Activity3 monthsPerceived effectiveness will be defined as ≥70% of participants indicate that study participation motivated them to increase their activity levels.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026